Artículos de revistas
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Fecha
2021-09-11Registro en:
Lancet. New York: Elsevier Science Inc, v. 398, n. 10304, p. 957-980, 2021.
0140-6736
10.1016/S0140-6736(21)01330-1
WOS:000695130500023
Autor
Imperial Coll London
Harvard TH Chan Sch Publ Hlth
WHO
Univ Calif Berkeley
Univ New South Wales
Natl Med Res Ctr Therapy & Prevent Med
Charles Univ Prague
Thomayer Hosp
Eduardo Mondlane Univ
Noncommunicable Dis Res Ctr
Tulane Univ
Natl Inst Biomed Innovat Hlth & Nutr
South African Med Res Council
Seoul Natl Univ
Yonsei Univ
ICMR Natl Inst Nutr
Natl Taiwan Univ
Pontificia Univ Catolica Chile
Univ Peruana Cayetano Heredia
Robert Koch Inst
Uppsala Univ
Univ Indonesia
Med Univ Gdansk
Univ Ghana
Caja Costarricense Seguro Social
Al Quds Univ
Qatar Univ
Birzeit Univ
Inst Mexicano Seguro Social
Flinders Univ S Australia
Mahidol Univ
BRAC Univ
Univ Copenhagen
Copenhagen Univ Hosp
Food & Nutr Res Inst
Urmia Univ Med Sci
Inst Nacl Ciencias Med & Nutr Salvador Zubiran
Univ Amsterdam
Minist Hlth
Modeling Hlth Res Ctr
Shahid Sadoughi Univ Med Sci
Erasmus MC
Univ Oslo
Leibniz Inst Prevent Res & Epidemiol BIPS
Natl Ctr Diabet Endocrinol & Genet
King Abdulaziz Univ
Dasman Diabet Inst
Aldara Hosp & Med Ctr
King Abdullah Int Med Res Ctr
Luxembourg Inst Hlth
Bispebjerg
Frederiksberg Univ Hosp
WHO Reg Off Eastern Mediterranean
Bombay Hosp & Med Res Ctr
CNRS
Univ Lille
Lille Univ Hosp
Western Norway Univ Appl Sci
Norwegian Sch Sport Sci
Madras Diabet Res Fdn
Zahedan Univ Med Sci
Kwame Nkrumah Univ Sci & Technol
Natl Inst Publ Hlth
Univ Porto
Norwegian Inst Publ Hlth
Univ Massachusetts
Abt Associates Inc
Univ Iceland
Univ Yaounde I
Univ Fed Pelotas
Univ Oulu
Oulu Univ Hosp
Banska Bystr Reg Author Publ Hlth
Neyshabur Univ Med Sci
Res Inst Endocrine Sci
Indian Council Med Res
Univ Sci & Technol
Med Univ Lodz
Univ Zagreb
Univ Autonoma Madrid CIBERESP
Univ Rzeszow
Univ Palermo
Pan Amer Hlth Org
Mohammed V Univ Rabat
Natl Inst Hlth Doutor Ricardo Jorge
NOVA Univ Lisbon
Univ Pernambuco
Baqai Inst Diabetol & Endocrinol
Universidade Federal de Santa Catarina (UFSC)
Dalhousie Univ
Jordan Univ Sci & Technol
Al Farabi Kazakh Natl Univ
Univ Sydney
Univ Auckland
Christian Med Coll Vellore
Univ Tunis El Manar
Cafam Univ Fdn
Univ Utah
Kazakh Natl Med Univ
Lithuanian Univ Hlth Sci
Universidade de São Paulo (USP)
BJ Med Coll
Sunder Lal Jain Hosp
Univ Republica
Univ Strasbourg
Inst Med Res & Med Plant Studies
Ufa Eye Res Inst
Nepal Hlth Res Council
Univ Southern Denmark
Univ Gothenburg
Universidade Federal do Rio de Janeiro (UFRJ)
Natl Inst Publ Hlth & Environm
Univ Turin
UCL
German Inst Human Nutr
Ctr Educ Med & Invest Clin
Toulouse Univ
Univ Zurich
Univ Hosp KU Leuven
Unisante
Univ Ghent
Univ Cent Venezuela
Bielefeld Univ
German Canc Res Ctr
Univ Andres
Inst Politecn Lisboa
Univ Zaragoza
Univ Coll Copenhagen
Munster Technol Univ
Hadassah Univ
Univ La Laguna
Univ Malta
Canadian Fitness & Lifestyle Res Inst
Istanbul Univ Cerrahpasa
Univ Fed Juiz de Fora
Gaetano Fucito Hosp
Karolinska Inst
Santiago Compostela Univ
Council Agr Res & Econ
Res & Educ Inst Child Hlth
India Diabet Res Fdn
Duke NUS Med Sch
ICMR Natl Inst Med Stat
Singapore Eye Res Inst
Acad Sinica
Capital Inst Pediat
Duke Univ
Kailuan Gen Hosp
Univ Oxford
Ahvaz Jundishapur Univ Med Sci
Gertner Inst Epidemiol & Hlth Policy Res
Univ Bern
Minist Hlth & Welf
Victor Babes Univ Med & Pharm Timisoara
CIBER Epidemiol & Salud Publ
Universidade Estadual Paulista (UNESP)
Med Univ Silesia
Carol Davila Univ Med & Pharm
Katholieke Univ Leuven
STAT Canada
Agcy Prevent & Social Med
Univ Southampton
IRCCS Neuromed
Inst Pasteur
Malawi Epidemiol & Intervent Res Unit
CIBEROBN
Univ Autonoma Madrid
Univ Debrecen
Univ Fed Rio Grande do Sul
CNR
Geneva Univ Hosp
Innovating Hlth Int
Univ Montreal
Sciensano
French Publ Hlth Agcy
Mediterranea Cardioctr
Univ Vale Rio dos Sinos
Natl Council Sci & Tech Res
Minist Hlth & Med Educ
Natl Inst Nutr
Univ Queensland
Ist Super Sanita
Univ Cuenca
Helmholtz Zentrum Munchen
Univ Med Greifswald
Minist Sante & Hyg Publ
Univ Hosp Dusseldorf
Natl Inst Cardiol
IRL 3189 ESS
Beth Israel Deaconess Med Ctr
Harvard Med Sch
Scuola Super Sant Anna
Univ Latvia
Minist Hlth & Med Serv
Hormozgan Univ Med Sci
Univ Tehran Med Sci
Univ Skovde
Natl Inst Nutr & Food Technol
Univ West Indies
Inst Hosp Mar Invest Med
CIBERCV
Univ Stellenbosch
Univ Duisburg Essen
Karadeniz Tech Univ
Univ Helsinki
Mashhad Univ Med Sci
Rafsanjan Univ Med Sci
Queens Univ Belfast
Tabriz Univ Med Sci
Fasa Univ Med Sci
Shiraz Univ Med Sci
Baqai Med Univ
Ctr Salud Villanueva Norte
Hosp Don Benito Villanueva de la Serena
Univ Insubria
Univ Fed Alagoas
Swiss Trop & Publ Hlth Inst
Univ Basel
Univ Tartu
Univ Sains Malaysia
Umea Univ
Universidade Federal de São Paulo (UNIFESP)
Hosp Univ Son Espases
Hosp Clin Porto Alegre
Kindai Univ
Kyoto Univ
I Horbachevsky Ternopil Natl Med Univ
Tel Aviv Univ
Hebrew Univ Jerusalem
Med Univ Warsaw
Jagiellonian Univ Med Coll
Univ Catania
Peking Univ
Wuqu Kawoq
Africa Hlth Res Inst
Univ Geneva
Universidade Federal de Minas Gerais (UFMG)
Univ Utrecht
Wageningen Univ
Med Res Fdn
BP Koirala Inst Hlth Sci
Univ Adelaide
Lund Univ
Aristotle Univ Thessaloniki
Inst Natl Sante & Rech Med
Paris Univ
Pontificia Univ Javeriana
PASs Hirszfeld Inst Immunol & Expt Therapy
Univ Agostinho Neto
Univ Politecn Madrid
Int Clin Res Ctr
Ctr Estudios Diabet AC
Univ Autonoma Santo Domingo
Natl Inst Hyg Epidemiol & Microbiol
Inst Clin & Expt Med
Childrens Mem Hlth Inst
Int Hellen Univ
Natl Ctr Cardiovasc Dis
Iceland Heart Assoc
Univ ICESI
Univ Estadual Montes Claros
Kings Coll London
Int Agcy Res Canc
Healis Sekhsaria Inst Publ Hlth
Eternal Heart Care Ctr & Res Inst
Univ Ibadan
Inst Clin Effectiveness & Hlth Policy
Natl Hlth Insurance Serv
Prevent Metab Disorders Res Ctr
Danish Canc Soc Res Ctr
Kermanshah Univ Med Sci
BRAC James P Grant Sch Publ Hlth
Univ Eastern Finland
Beijing Inst Ophthalmol
Universidade Federal de Pernambuco (UFPE)
Kyushu Univ
Univ Bergen
Chinese Ctr Dis Control & Prevent
Joep Lange Inst
Chron Dis Res Ctr
Univ Hong Kong
Chinese Univ Hong Kong
Univ Western Australia
French Natl Res Inst Sustainable Dev
Celal Bayar Univ
Fdn Oftalmol Santander
Univ Oran 1
Minist Hlth & Sports
Sante Publ France
Vrije Univ Amsterdam Med Ctr
Amer Univ Beirut
Cairo Univ
Med Univ Varna
Univ Tokyo
Universidade Estadual de Maringá (UEM)
Hosp Sick Children
Deakin Univ
Tokyo Metropolitan Inst Gerontol
Hadassah Univ Med Ctr
Norwegian Univ Sci & Technol
Univ Melbourne
Univ Hosp Ctr Zagreb
Heart Fdn
Guangzhou 12th Hosp
Univ Eugenio Maria Hostos
Simon Fraser Univ
Inst Mol & Clin Ophthalmol Basel
WHO Country Off
Guilan Univ Med Sci
Univ Opole
Finnish Inst Hlth & Welf
Univ Ljubljana
Univ Crete
Natl & Kapodistrian Univ Athens
Sree Chitra Tirunal Inst Med Sci & Technol
Harokopio Univ
Maharajgunj Med Campus
Aarhus Univ
Johns Hopkins Bloomberg Sch Publ Hlth
Natl Inst Epidemiol
Univ Munster
Israel Ctr Dis Control
Res Inst Primordial Prevent Noncommunicable Dis
Amsterdam UMC Publ Hlth Res Inst
Kyrgyz State Med Acad
Res Inst Child Nutr
Shahid Beheshti Univ Med Sci
Univ Cambridge
Mazandaran Univ Med Sci
Hypertens Res Ctr
Med Univ Innsbruck
VASCage
Muhimbili Univ Hlth & Allied Sci
Natl Canc Ctr
Univ Coll South Denmark
Oulu Deaconess Inst Fdn
Tartu Univ Clin
Kansai Med Univ
Minist Hlth & Wellness
Univ Groningen
North West Univ
Amrita Inst Med Sci
All India Inst Med Sci
African Populat & Hlth Res Ctr
Minist Salud Publ
Sahlgrens Acad
Endocrinol & Metab Res Ctr
Univ Publ Hlth
Natl Univ Singapore
Tampere Univ Hosp
Tampere Univ
Univ Douala
Univ Cape Town
West Virginia Univ
Oswaldo Cruz Fdn Rene Rachou Res Inst
Shanghai Inst Nutr & Hlth
Taipei Med Univ
Natl Inst Hlth Dev
Univ San Martin de Porres
Consejeria Sanidad Junta Castilla & Leon
Univ Fed Ciencias Saude Porto Alegre
Norrbotten Cty Council
Univ Fed Ouro Preto
Univ Coimbra
Coimbra Univ Hosp Ctr
Inst Neurosci Natl Res Council
Baker Heart & Diabet Inst
Agr Univ Athens
Hosp Israelita Albert Einstein
SB RAS Fed Res Ctr Inst Cytol & Genet
Univ Otago
Univ Padua
Gothenburg Univ
Univ Rijeka
Lausanne Univ Hosp
Univ Lausanne
Escola Nacl Saude Publ Sergio Arouca
Emory Univ
Univ Estadual Centro Oeste
UiT Arctic Univ Norway
ICMR Natl Ctr Dis Informat & Res
Cape Peninsula Univ Technol
Inst Conmemorat Gorgas Estudios Salud
Brown Univ
Univ Edinburgh
Univ Coll Dublin
Inst Nutr Ctr Amer & Panama
Univ Lisbon
Womens Social & Hlth Studies Fdn
Univ Firenze
Ain Shams Univ
Psychiat & Psychol Res Canter
Isfahan Cardiovasc Res Ctr
Strasbourg Univ Hosp
Univ Pecs
Mulago Hosp
Univ Limpopo
Univ Med Sci Cienfuegos
Royal Coll Surgeons Ireland
La Trobe Univ
Int Inst Mol & Cell Biol
Dept Publ Hlth
Univ Brescia
Ludwig Maximilians Univ Munchen
Croatian Inst Publ Hlth
Univ Kebangsaan Malaysia
Bushehr Univ Med Sci
Ulm Univ
Dept Stat
Kobe Univ
Suraj Eye Inst
Natl Inst Hyg & Epidemiol
Univ Med & Pharm Ho Chi Minh City
Natl Hosp Endocrinol
Hanoi Med Univ
LifeDoc Hlth
Univ Turku
Heartfile
Eastern Mediterranean Publ Hlth Network
Univ Manchester
Tachikawa Gen Hosp
Univ Abuja
Korea Ctr Dis Control & Prevent
Japan Wildlife Res Ctr
Istanbul Univ
Univ Fed Parana
Univ Madeira
Univ Novi Sad
Osteoporosis Res Ctr
UniSante
Inst Canc Res Prevent & Clin Network
Inst Clin & Sci Ophthalmol & Acupuncture Jonas &
IRCCS Ente Osped Specializzato Gastroenterol S de
Zayed Univ
Catholic Univ Daegu
Jivandeep Hosp
Ctr Invest Saude Angola
Griffith Univ
Natl Dent Care Ctr Singapore
Vietnam Natl Heart Inst
Clin Med Avanzada Dr Abel Gonzalez
Univ Sarajevo
Cardiovasc Prevent Ctr Udine
Publ Hlth Agcy Catalonia
Univ Split
Ardabil Univ Med Sci
London Sch Hyg & Trop Med
Alborz Univ Med Sci
Pure Earth
Univ Putra Malaysia
Univ Malaya
Sotiria Hosp
Univ Valencia
Univ Philippines
Slovak Acad Sci
Univ San Martin Porres
Minas Gerais State Secretariat Hlth
CS S Agustin Ibsalut
Amsterdam Inst Global Hlth & Dev
Univ Nove de Julho
Publ Hlth Agcy Canada
Canarian Hlth Serv
Univ Ind Santander
Assoc Calabrese Epatol
Sahlgrens Univ Hosp
Sitaram Bhartia Inst Sci & Res
Koc Univ
Natl Inst Hlth
Catalan Dept Hlth
South Karelia Social & Hlth Care Dist
German Ctr Cardiovasc Res
McMaster Univ
Hosp Italiano Buenos Aires
Acad Med Ctr Univ Amsterdam
George Inst Global Hlth
Ctr Oral Hlth Serv & Res Mid Norway
Lagos State Univ
Nippon Med Sch
Sungkyunkwan Univ
Shahrekord Univ Med Sci
Finnish Inst Occupat Hlth
Publ Hlth Promot & Dev Org
St Vincents Hosp
Diponegoro Univ
Univ Bari
Inst Reg Sante Publ
Univ Bordeaux
Oslo Metropolitan Univ
Univ Leuven
Univ Bonn
Natl Inst Hyg
Jikei Univ
Fu Jen Catholic Univ
Natl Stat Off
Univ Lincoln
Cent Univ Kerala
Amsterdam Publ Hlth Res Inst
Natl Inst Hlth Res & Dev
Hlth Serv Murcia
Inst Invest Sanitaria Illes Balears
CIBER Epidemiol Salud Publ
Hellen Hlth Fdn
Govt Med Coll
Sefako Makgatho Hlth Sci Univ
Addis Ababa Univ
Israel Def Forces Med Corps
Univ Ctr Occidental Lisandro Alvarado
Univ Tampere
Icahn Sch Med Mt Sinai
Hanoi Univ Publ Hlth
Inst Trop Med
Univ Miguel Hernandez
Univ Lorraine
North Karelia Ctr Publ Hlth
Univ Witwatersrand
Inst Med Res
Capital Med Univ
Xinjiang Med Univ
Shanghai Educ Dev Co Ltd
Orebro Univ
St Georges Univ London
Med Univ Vienna
Komfo Anokye Teaching Hosp
Minist Agr & Rural Affairs
Fudan Univ
Shanghai Educ Dev
Univ Cyprus
Niigata Univ
Iran Univ Med Sci
Ctr Estudios Nutr Infantil
Jiangsu Prov Ctr Dis Control & Prevent
Sun Yat Sen Univ
West Kazakhstan Med Univ
Inner Mongolia Med Univ
Institución
Resumen
Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. Copyright (C) 2021 World Health Organization; licensee Elsevier.